Association of preoperative psychopharmacological treatment and the risk of new chronic opioid use after hip and knee arthroplasty: a Danish registry-based cohort study of 73,033 procedures
DOI:
https://doi.org/10.2340/17453674.2025.44228Keywords:
Arthroplasty, Hip, Knee, OsteoarthrosisAbstract
Background and purpose: Chronic opioid use is of great concern worldwide. Thus, identification of risk factors for new chronic opioid use (COU) after hip and knee arthroplasty is imperative to target preventive strategies. Depression/anxiety may be risk factors for new COU. However, no studies have investigated whether any or subgroups of preoperative psychopharmacological treatments (PPTs) are risk factors for new COU after hip and knee arthroplasty in a nationwide setting, which was the aim of the present study.
Methods: This population-based cohort study included 40,476 primary hip and 32,557 primary knee arthroplasties from 2015 to 2022 using the Danish Hip/Knee Arthroplasty Registers. Preoperative opioid users were excluded. Dispensing records of psychotropics and opioids were obtained from the Danish National Prescription Registry. Relative risks of new COU were estimated with 95% confidence intervals (CI) using binary regression and adjusted for age, sex, and Charlson Comorbidity Index.
Results: Among hip patients using psychopharmacological treatments (PPTs), 4.6% (202/4,439) had new COU compared with 2.2% (788/36,037) of patients not using PPTs, corresponding to an adjusted relative risk of 1.8 (CI 1.6–2.1). Among total and unicompartmental knee arthroplasties, 9.1% (298/3,261) and 6.4% (59/926) had new COU compared with 4.7 (1,011/21,529) and 2.9% (201/6,841) of patients not using PPTs, corresponding to adjusted relative risks of 1.8 (CI 1.6–2.1) and 2.0 (CI 1.5–2.7), respectively. Analyses of PPT subgroups showed similar results.
Conclusion: Hip and knee arthroplasty patients using PPTs have almost a twofold increased risk of new COU. This emphasizes the need for prevention strategies in these patients.
Downloads
References
Mackiewicz M, Brown R E, Price E T, Sargent L. Quality of life in older adults with opioid use disorder: a scoping review. Geriatr Nurs 2022; 46: 118-24. doi: 10.1016/j.gerinurse.2022.05.002. DOI: https://doi.org/10.1016/j.gerinurse.2022.05.002
Spencer M R, Miniño A M, Warner M. Drug overdose deaths in the United States, 2001–2021. NCHS Data Brief, no 457. Hyattsville, MD: National Center for Health Statistics; 2022. doi: 10.15620/cdc:122556. DOI: https://doi.org/10.15620/cdc:122556
Lancet Regional Health—Americas. Opioid crisis: addiction, overprescription, and insufficient primary prevention. Lancet Reg Health Am 2023; 23: 100557. doi: 10.1016/j.lana.2023.100557. DOI: https://doi.org/10.1016/j.lana.2023.100557
Lægemiddelstatistikregisteret. Forbruget af opioider falder fortsat; 2023. https://sundhedsdatastyrelsen.dk/Media/638676188093096917/Forbrug_opioider_falder_fortsat_2018_2023.pdf
Klenø A N, Sørensen H T, Pedersen A B. Time trends in use of non-steroidal anti-inflammatory drugs and opioids one year after total hip arthroplasty due to osteoarthritis during 1996–2018: a population-based cohort study of 103,209 patients. Osteoarthritis Cartilage 2022; 30(10): 1376-84. doi: 10.1016/j.joca.2022.07.006. DOI: https://doi.org/10.1016/j.joca.2022.07.006
Brummett C M, Waljee J F, Goesling J, Moser S, Lin P, Englesbe M J, et al. New persistent opioid use after minor and major surgical procedures in US adults. JAMA Surg 2017; 152(6): e170504. doi: 10.1001/jamasurg.2017.0504. Erratum: JAMA Surg 2019; 154(3): 272. doi: 10.1001/jamasurg.2018.5476. DOI: https://doi.org/10.1001/jamasurg.2017.0504
VanIderstine C, Johnston E. Risk factors for prolonged opioid use following total hip arthroplasty and total knee arthroplasty: a narrative review of recent literature. Ann Pharmacother 2023; 57(7): 837-46. doi: 10.1177/10600280221133078. DOI: https://doi.org/10.1177/10600280221133078
Jørgensen C C, Petersen M, Kehlet H, Aasvang E K. Analgesic consumption trajectories in 8975 patients 1 year after fast-track total hip or knee arthroplasty. Eur J Pain 2018 Apr 20. doi: 10.1002/ejp.1232. Online ahead of print. DOI: https://doi.org/10.1002/ejp.1232
Jensen C B, Troelsen A, Foss N B, Nielsen C S, Lindberg-Larsen M, Gromov K. 10-year evolution of day-case hip and knee arthroplasty: a Danish nationwide register study of 166,833 procedures from 2010 to 2020. Acta Orthop 2023; 94: 178-84. doi: 10.2340/17453674.2023.11961. DOI: https://doi.org/10.2340/17453674.2023.11961
Rupp M, Lau E, Kurtz S M, Alt V. Projections of primary TKA and THA in Germany from 2016 through 2040. Clin Orthop Relat Res 2020; 478(7): 1622-33. doi: 10.1097/CORR.0000000000001214. DOI: https://doi.org/10.1097/CORR.0000000000001214
Schmidt M, Pedersen L, Sørensen H T. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol 2014; 29(8): 541-9. doi: 10.1007/s10654-014-9930-3. DOI: https://doi.org/10.1007/s10654-014-9930-3
Benchimol E I, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al.; RECORD Working Committee. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med 2015; 12(10): e1001885. doi: 10.1371/journal.pmed.1001885. DOI: https://doi.org/10.1371/journal.pmed.1001885
Danish Hip Arthroplasty Register. National Annual Report for 2022. The Danish Clinical Quality Program – National Clinical Registries (RKKP); 2023.
Danish Knee Arthroplasty Register. National Annual Report for 2022. The Danish Clinical Quality Program – National Clinical Registries (RKKP); 2023.
Pottegård A, Schmidt S A J, Wallach-Kildemoes H, Sørensen H T, Hallas J, Schmidt M. Data resource profile: the Danish National Prescription Registry. Int J Epidemiol 2017; 46(3): 798-798f. doi: 10.1093/ije/dyw213. DOI: https://doi.org/10.1093/ije/dyw213
Pottegård A, Hallas J. Assigning exposure duration to single prescriptions by use of the waiting time distribution. Pharmacoepidemiol Drug Saf 2013; 22(8): 803-9. doi: 10.1002/pds.3459. DOI: https://doi.org/10.1002/pds.3459
Kornvig S, Kehlet H, Jørgensen C C, Fink-Jensen A, Videbech P, Jakobsen T, et al. Preoperative psychopharmacological treatment is not a risk factor for poorer patient-reported improvements 12 months after hip or knee arthroplasty: a multicenter registry-based cohort study of 7,247 procedures. J Arthroplasty 2025; 40(4): 860-6.e5. doi: 10.1016/j.arth.2024.10.026. DOI: https://doi.org/10.1016/j.arth.2024.10.026
Edwards N M, Varnum C, Overgaard S, Nikolajsen L, Christiansen C F, Pedersen A B. Risk factors for new chronic opioid use after hip fracture surgery: a Danish nationwide cohort study from 2005 to 2016 using the Danish multidisciplinary hip fracture registry. BMJ Open 2021; 11(3): e039238. doi: 10.1136/bmjopen-2020-039238. DOI: https://doi.org/10.1136/bmjopen-2020-039238
Schmidt M, Schmidt S A, Sandegaard J L, Ehrenstein V, Pedersen L, Sørensen H T. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 2015; 7: 449-90. doi: 10.2147/CLEP.S91125. DOI: https://doi.org/10.2147/CLEP.S91125
Thygesen S K, Christiansen C F, Christensen S, Lash T L, Sørensen H T. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol 2011; 11: 83. doi: 10.1186/1471-2288-11-83. DOI: https://doi.org/10.1186/1471-2288-11-83
Inacio M C, Hansen C, Pratt N L, Graves S E, Roughead E E. Risk factors for persistent and new chronic opioid use in patients undergoing total hip arthroplasty: a retrospective cohort study. BMJ Open 2016; 6(4): e010664. doi: 10.1136/bmjopen-2015-010664. DOI: https://doi.org/10.1136/bmjopen-2015-010664
Cancienne J M, Patel K J, Browne J A, Werner B C. Narcotic use and total knee arthroplasty. J Arthroplasty 2018; 33(1): 113-18. doi: 10.1016/j.arth.2017.08.006. DOI: https://doi.org/10.1016/j.arth.2017.08.006
Bedard N A, Pugely A J, Dowdle S B, Duchman K R, Glass N A, Callaghan J J. Opioid use following total hip arthroplasty: trends and risk factors for prolonged use. J Arthroplasty 2017; 32(12): 3675-9. doi: 10.1016/j.arth.2017.08.010. DOI: https://doi.org/10.1016/j.arth.2017.08.010
Bedard N A, Pugely A J, Westermann R W, Duchman K R, Glass N A, Callaghan J J. Opioid use after total knee arthroplasty: trends and risk factors for prolonged use. J Arthroplasty 2017; 32(8): 2390-4. doi: 10.1016/j.arth.2017.03.014. DOI: https://doi.org/10.1016/j.arth.2017.03.014
Bedard N A, DeMik D E, Dowdle S B, Callaghan J J. Trends and risk factors for prolonged opioid use after unicompartmental knee arthroplasty. Bone Joint J 2018; 100-B(1 Supple A): 62-7. doi: 10.1302/0301-620X.100B1.BJJ-2017-0547.R1. DOI: https://doi.org/10.1302/0301-620X.100B1.BJJ-2017-0547.R1
Moffat A K, Pratt N L, Kerr M, Kalisch Ellett L M, Roughead E E. Risk of chronic opioid use in older persons with pre-existing anxiety. J Opioid Manag 2019; 16(1): 59-66. doi: 10.5055/jom.2020.0551. DOI: https://doi.org/10.5055/jom.2020.0551
Park T W, Saitz R, Ganoczy D, Ilgen M A, Bohnert A S. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ 2015; 350: h2698. doi: 10.1136/bmj.h2698. DOI: https://doi.org/10.1136/bmj.h2698
Sørensen A M S, Rasmussen L, Ernst M T, Mogensen S H, Laursen M V, Jimenez-Solem E, et al. Use of tramadol and other analgesics following media attention and risk minimization actions from regulators: a Danish nationwide drug utilization study. Eur J Clin Pharmacol 2021; 77(4): 617-24. doi: 10.1007/s00228-020-03016-6. DOI: https://doi.org/10.1007/s00228-020-03016-6
Klenø A N, Stisen M B, Edwards N M, Mechlenburg I, Pedersen A B. Socioeconomic status and use of analgesic drugs before and after primary hip arthroplasty: a population-based cohort study of 103,209 patients during 1996–2018. Acta Orthop 2022; 93: 171-8. doi: 10.2340/17453674.2021.955. DOI: https://doi.org/10.2340/17453674.2021.955
Danish Pharmaceutical Information. Medicin.dk. Accessed December 16, 2024. Available from: http://pro.medicin.dk
Additional Files
Published
How to Cite
License
Copyright (c) 2025 Simon Kornvig, Henrik Kehlet, Christoffer C Jørgensen, Anders Fink-Jensen, Poul Videbech, Alma B Pedersen, Claus Varnum
This work is licensed under a Creative Commons Attribution 4.0 International License.
